The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples